课题基金 / 基金详情

Distribution of CaR in brain and its role

Distribution of CaR in brain and its role
CaR在脑中的分布及其作用
批准号:
08457015
负责人:
SORIMACHI Masaru
金额:
$3.97万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

SORIMACHI Masaru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our purpose of this study was to clarify the physiological role of Ca2+-sensing receptor (CaR) in the brain. We at first investigated the distribution of CaR in Japanese monkey brain using antibody against CaR.Only one kind of antibody against CaR fusion protein exhibited immunoreactivity in the brain. Immunoreactive beads-like nerve terminals were scattered in various brain regions including cerebra'neocortex, hippocampus, dentate gyrus, nucleus caudalis (faced to lateral vantricle), lateral and medial septum, striae terminalis, Meynert nucleus, amygdala area, thalamus (faced to lateral ventricle), hypothalamus (faced to third vantricle), midbrain interpeduncular nucleus, cerbellar cortex (surrounding Purkinje neuron), pons and medulla (particularly in area postrema). On the other hand, unlike the results in rat brain, we found no immunoreactivity on the wall of vessels. We next investigated the effect of antibody on the spontaneouus ionic cuurrents recorded in amygdala neurons to see whether CaR is involved in synaptic transmission. Application of antibody did not show any effect on ionic currents, suggesting that antibody did not recognize native CaR or uunaffected the spontaneous release of neurotransmitter from nerve terminals.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Jin, Y.-H., Munakata, M., Morimoto, H., and Akaike, N.: "Efects of benzodiazepine receptor agonists in neurones acutely dissociated from the rat neostriatum" NeuroRep.8. 3197-3200 (1997)
Jin, Y.-H.、Munakata, M.、Morimoto, H. 和 Akaike, N.:“苯二氮卓受体激动剂对与大鼠新纹状体急性分离的神经元的影响” NeuroRep.8。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Uneyama, C., Uneyama, H., et al.: "Kinetic characteristics of thrombin receptor-mediated responses in rat megakaryocytes" Eur.J.Pharmacol.319. 299-305 (1997)
Uneyama, C.、Uneyama, H. 等人:“大鼠巨核细胞中凝血酶受体介导的反应的动力学特征”Eur.J.Pharmacol.319。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sorimachi,M.,Rhee,J.S.et al.: "Mechanisms of GABA-and glycine-induced increases of cytosolic Ca^<2+>concentrations in chick embryo ciliary ganglino cells." J.Neurochem.69. 797-805 (1997)
Sorimachi,M.,Rhee,J.S.等人:“GABA 和甘氨酸诱导鸡胚睫状神经节细胞胞质 Ca^2 浓度增加的机制”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Murai, Y., Ishibashi, H., et al.: "Ca^<2+>-activated K^+ currents in rat locus coeruleus neurons induced by experimental ishemia,anoxia,and hypoglycemia," J.Neurophysiol.78. 2674-2681 (1997)
Murai,Y.,Ishibashi,H.,等人:“由实验性缺血、缺氧和低血糖诱导的大鼠蓝斑神经元中Ca 2+ 激活的K 2 电流”,J.Neurophysiol.78。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Mechanism underlying the spontaneous changes in the cytosolic CaィイD12+ィエD1concentrations in rat adrenal chromaffin cells
    • 批准号:
      10670045
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1998
    • 负责人:
      SORIMACHI Masaru
    • 依托单位:
    Phramacological characteristics of acetylcholine receptors in chick ciliary ganglion neurons
    • 批准号:
      05808076
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.22万
    • 财政年份:
      1993
    • 负责人:
      SORIMACHI Masaru
    • 依托单位:
    国内基金
    海外基金
    基于多组学与可视化免疫动态成像技术解析EZH2抑制对增强CAR-NK细胞抗AML效应的机制研究
    • 批准号:
      JCZRLH202600775
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于CD99靶点CAR-T产品治疗T-ALL/AML的安全性与有效性研究
    • 批准号:
      JCZRLH202600888
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    自调控型CAR-M细胞抑制心脏移植排斥反应机制研究
    • 批准号:
      JCZRQNB202600583
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    报告基因PET显像无创引导下的放射性配体疗法用于重塑肿瘤微环境以增强CAR-T细胞治疗疗效的研究
    • 批准号:
      JCZRQNB202600678
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: